 |
市场调查报告书
商品编码
1529558
无菌注射剂市场：依分子类型、药物类型、适应症、给药途径及地区Sterile Injectables Market, By Molecule Type, By Drug Type, By Disease Indication, By Route of Administration (Intravenous, Intramuscular, Subcutaneous, and Others), By Geography |
||||||
价格
简介目录
预计2024年全球无菌注射剂市场规模为5,861亿美元，预计2031年将达9,841亿美元，2024年至2031年复合年增长率为7.7%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2023年 | 2024年市场规模 | 5861亿美元 |
| 实际资料 | 2019-2023 | 预测期 | 2024-2031 |
| 2024-2031 年预测期复合年增长率 | 7.70% | 2031 年金额预测 | 9841亿美元 |
图：2024 年按地区分類的无菌注射剂市场占有率(%)
全球无菌注射剂市场的成长是由于慢性病盛行率上升以及全球老年人口越来越容易患此类疾病而推动的。无菌注射剂用于肿瘤学、自体免疫疾病、血液学、眼科和麻醉学等治疗领域。此外，对生技药品的需求不断增加以及这些药物的价格实惠正在推动市场成长。然而，与无菌注射剂生产相关的严格监管规范可能会阻碍预测期内的市场成长。
市场动态：
全球无菌注射剂市场的成长是由全球癌症和其他慢性疾病发生率上升所推动的。不断增长的老年人口更容易患慢性病，也可能推动对无菌注射剂的需求。此外，生技药品因其优越的功效而相对于传统药物越来越受欢迎，也可能提供新的市场成长机会。然而，由于监管机构实施严格的品管标准，与无菌注射剂相关的高製造成本可能会阻碍市场成长。由于製造过程中的污染问题而导致的产品召回可能会阻碍市场成长。开发有效生物相似药的持续研发活动可能在不久的将来提供市场成长机会。
本研究的主要特点
- 该报告对全球无菌注射剂市场进行了详细分析，并提供了以 2023 年为基准年的预测期（2024-2031 年）的市场规模（十亿美元）和年复合成长率（CAGR%） 。它。
- 它还说明了各个细分市场的潜在商机，并为该市场提供了一系列有吸引力的投资提案。
- 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
- 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球无菌注射剂市场的主要企业。
- 该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
- 全球无菌注射剂市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
- 相关人员可以透过分析全球无菌注射剂市场时所使用的各种策略矩阵来促进决策。
目录
第一章 研究目的与前提
- 研究目的
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行概述
- 一致的机会地图 (COM)
第三章市场动态、法规及趋势分析
- 市场动态
- 促进因素
- 抑制因素
- 机会
- 影响分析
- 市场趋势
- 监管场景
- 收购和合作场景
- 资金筹措和投资
- PEST分析
- 波特的分析
第四章全球无菌注射剂市场 - 冠状病毒 (COVID-19) 大流行的影响
- 整体影响
- 政府倡议
- COVID-19 对市场的影响
第五章全球无菌注射剂市场，依分子类型，2019-2031（十亿美元）
- 介绍
- 高分子
- 小分子
第六章全球无菌注射剂市场，依药物类型，2019-2031（十亿美元）
- 介绍
- 单株抗体
- 细胞激素
- 胰岛素
- 肽激素
- 血液因素
- 疫苗
- 免疫球蛋白
- 胜肽抗生素
- 其他的
第七章 2019-2031 年全球无菌注射剂市场（按指标划分）（十亿美元）
- 介绍
- 癌症
- 糖尿病
- 心血管疾病
- 肌肉骨骼疾病
- 中枢神经系统疾病
- 感染疾病
- 其他的
第 8 章 全球无菌注射剂市场（依给药途径），2019-2031 年（十亿美元）
- 介绍
- 静脉
- 肌肉注射
- 皮下的
- 其他的
第 9 章 全球无菌注射剂市场，依通路划分，2019-2031 年（十亿美元）
- 介绍
- 医院药房
- 零售药房
- 网路药房
第10章全球无菌注射剂市场，按地区，2019-2031（十亿美元）
- 介绍
- 拉丁美洲
- 欧洲
- 亚太地区
- 中国
- 印度
- 日本
- 东南亚国协
- 澳洲
- 韩国
- 其他亚太地区
- 中东
- 海湾合作委员会国家
- 以色列
- 其他中东地区
- 非洲
- 北非
- 中部非洲
- 南非
第十一章竞争格局
- 公司简介
- Pfizer Inc.
- Merck &Co., Inc.
- Johnson &Johnson
- Baxter International Inc.
- Novartis AG
- Sanofi SA
- GlaxoSmithKline plc（GSK）
- AstraZeneca PLC
- Gilead Sciences, Inc.
- Amgen Inc.
- AbbVie Inc.
- Teva Pharmaceutical Industries Ltd.
- Bayer AG
- Fresenius SE &Co. KGaA（Fresenius Kabi）
- Becton, Dickinson and Company（BD）
- F. Hoffmann-La Roche Ltd
- Eli Lilly and Company
第十二章分析师建议
- 上升和下降
- 综合机会图
第十三章参考文献与调查方法
- 参考
- 调查方法
简介目录
Product Code: CMI201
Global sterile injectables market is estimated to be valued at USD 586.1 Bn in 2024 and is expected to reach USD 984.1 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.7% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 586.1 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 7.70% | 2031 Value Projection: | US$ 984.1 Bn |
Figure. Sterile Injectables Market Share (%), By Region 2024
Global sterile injectables market growth is driven by rising incidence of chronic diseases along with growing geriatric population worldwide who are more susceptible to such diseases. Sterile injectables are used in therapeutic areas like oncology, autoimmune diseases, hematology, ophthalmology, anesthesia, and others. Moreover, rising demand for biologics and affordability of these drugs can drive the market growth. However, stringent regulatory norms associated with sterile injectables production can hamper the market growth during the forecast period.
Market Dynamics:
Global sterile injectables market growth is driven by growing incidence of cancer and other chronic diseases globally. Growing geriatric population prone to chronic medical conditions can also boost demand for sterile injectables. Moreover, rising popularity of biologics over conventional drugs due to superior efficacy can offer new market growth opportunities. However, high production costs associated with sterile injectables due to stringent quality control standards imposed by regulatory authorities can hamper the market growth. Product recalls owing to contamination issues during manufacturing can hamper the market growth. Ongoing R&D activities for developing effective biosimilars can offer market growth opportunities in the near future.
Key Features of the Study:
- This report provides in-depth analysis of the global sterile injectables market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook and competitive strategies adopted by key players.
- It profiles key players in the global sterile injectables market based on the following parameters - company highlights, products portfolio, key highlights, financial performance and strategies.
- Key companies covered as a part of this study include Pfizer Inc., Baxter International Inc., Abbott Laboratories and GlaxoSmithKline plc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion and marketing tactics.
- Global sterile injectables market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sterile injectables market
Detailed Segmentation-
- By Molecule Type
- Large Molecules
- Small Molecule
- By Drug Type
- Monoclonal Antibodies
- Cytokines
- Insulin
- Peptide Hormones
- Blood Factors
- Vaccines
- Immunoglobulins
- Peptide Antibiotics
- Others
- By Disease Indication
- Cancer
- Diabetes
- Cardiovascular Disorders
- Musculoskeletal Disorders
- CNS disorders
- Infectious Disorders
- Others
- By Route of Administration
- Intravenous (IV)
- Intramuscular (IM)
- Subcutaneous (SC)
- Others
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Pfizer Inc.
- Merck & Co., Inc.
- Johnson & Johnson
- Baxter International Inc.
- Novartis AG
- Sanofi S.A.
- GlaxoSmithKline plc (GSK)
- AstraZeneca PLC
- Gilead Sciences, Inc.
- Amgen Inc.
- AbbVie Inc.
- Teva Pharmaceutical Industries Ltd.
- Bayer AG
- Fresenius SE & Co. KGaA (Fresenius Kabi)
- Becton, Dickinson and Company (BD)
- Hoffmann-La Roche Ltd
- Eli Lilly and Company
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Molecule Type
- Market Snapshot, By Drug Type
- Market Snapshot, By Disease Indication
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Sterile Injectables Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Sterile Injectables Market, By Molecule Type, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Large Molecules
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Small Molecule
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Sterile Injectables Market, By Drug Type, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Monoclonal Antibodies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Cytokines
- Mammography
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Insulin
- Chest X-ray
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Peptide Hormones
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Blood Factors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Vaccines
- Mammography
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Immunoglobulins
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Peptide Antibiotics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Sterile Injectables Market, By Disease Indication, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Diabetes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Cardiovascular Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Musculoskeletal Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- CNS disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Infectious Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Sterile Injectables Market, By Route of Administration, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Intravenous
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Intramuscular
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Subcutaneous
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
9. Global Sterile Injectables Market, By Distribution Channel, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
10. Global Sterile Injectables Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
11. Competitive Landscape
- Company Profiles
- Pfizer Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck & Co., Inc.
- Johnson & Johnson
- Baxter International Inc.
- Novartis AG
- Sanofi S.A.
- GlaxoSmithKline plc (GSK)
- AstraZeneca PLC
- Gilead Sciences, Inc.
- Amgen Inc.
- AbbVie Inc.
- Teva Pharmaceutical Industries Ltd.
- Bayer AG
- Fresenius SE & Co. KGaA (Fresenius Kabi)
- Becton, Dickinson and Company (BD)
- F. Hoffmann-La Roche Ltd
- Eli Lilly and Company
- Pfizer Inc.
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
02-2729-4219
+886-2-2729-4219
全球无菌注射 CDMO 市场：市场规模、份额和趋势分析 - 按分子、按产品、按服务、按治疗领域、按给药途径、按最终用途、按地区、细分市场预测，2024-2030 年
注射市场：按分子类型、药物类别、注射途径和应用划分 - 2024-2030 年全球预测
小分子无菌注射药物市场 - 按药物类型（抗生素、麻醉药、抗病毒药）、产品类型、给药途径、应用（肿瘤、传染病、糖尿病）、配销通路- 全球预测（2024 - 2032）
全球小分子无菌注射药物市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测
无菌注射剂市场，按药物类型、应用、给药途径、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测
冷冻干燥注射剂的全球市场规模、份额、成长分析（按药物、按适应症）-产业预测，2023-2030年
肌内药物稀释剂市场：按产品和应用分类 - 全球预测 2024-2030
无菌注射药物市场 - 2023-2031 年全球产业分析、规模、份额、成长、趋势与预测
慢性病缓释注射剂市场
到 2030 年无菌注射剂市场预测：按药物类型、分子类型、途径、给药配销通路、应用和地区进行的全球分析
▼